Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$163 Buy
20
+7
+54% +$61 ﹤0.01% 5138
2026
Q1
$91 Buy
+13
New +$595 ﹤0.01% 4959
2025
Q3
– Sell
-1
Closed -$26 – 5603
2025
Q2
$26 Hold
1
– – ﹤0.01% 5138
2025
Q1
$28 Hold
1
– – ﹤0.01% 5163
2024
Q4
$35 Buy
+1
New +$40 ﹤0.01% 5208
2021
Q4
– Sell
-9
Closed -$1K – 4438
2021
Q3
$1K Hold
9
– – ﹤0.01% 4701
2021
Q2
$1K Buy
+9
New +$712 ﹤0.01% 4826

Other funds holding IMMP

Barclays's IMMP Position: Q2 2026 in Review

Barclays increased its Immutep (IMMP) stake by 54% in Q2 2026, buying an estimated $61 and bringing the position to 20 shares worth $163. The position accounts for ﹤0.01% of the portfolio, ranked #5138.

Barclays first reported a position in IMMP in Q2 2021 and has held it in 7 quarters since. The position peaked at $1K in Q3 2021. 24 funds tracked by Wall St. Rank hold IMMP as of Q2 2026.

  • Barclays held 20 shares of Immutep worth $163 as of Q2 2026.
  • Barclays bought 7 Immutep shares in Q2 2026, an estimated $61.
  • Immutep made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5138 holding.
  • Barclays first reported a position in Immutep in Q2 2021 and has held it in 7 quarters since.
  • Barclays's Immutep position peaked at $1K in Q3 2021.
  • 24 funds tracked by Wall St. Rank held Immutep as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.